已收录 268921 条政策
 政策提纲
  • 暂无提纲
Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea
[摘要] Study ObjectivesThere remains an important and unmet need for fully effective and acceptable treatments in obstructive sleep apnea (OSA). At present, there are no approved drug treatments. Dronabinol has shown promise for OSA pharmacotherapy in a small dose-escalation pilot study. Here, we present initial findings of the Phase II PACE (Pharmacotherapy of Apnea by Cannabimimetic Enhancement) trial, a fully blinded parallel groups, placebo-controlled randomized trial of dronabinol in people with moderate or severe OSA.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 生理学
[关键词] obstructive sleep apnea;pharmacotherapy;cannabinoid;clinical trial [时效性] 
   浏览次数:4      统一登录查看全文      激活码登录查看全文